ReviewCurrent atherosclerosis reports2021

Selective Peroxisome Proliferator-Activated Receptor Alpha Modulators (SPPARMα) in the Metabolic Syndrome: Is Pemafibrate Light at the End of the Tunnel?

Jean-Charles Fruchart et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.